Asim Afaq, MBBS, FRCR

• Clinical Associate Professor

• Department: Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Rima A. Afifi, PhD, MPH

• Professor

• Department: Community and Behavioral Health
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Alaa AlBashayreh, PhD, MSHI, RN

• Associate

• Department: Nursing
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Bryan G. Allen, MD, PhD

• Associate Professor

• Department: Radiation Oncology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Program Co-Leader

Carryn Anderson, MD

• Clinical Associate Professor

• Department: Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Michael G. Anderson, PhD

• Professor

• Department: Molecular Physiology and Biophysics, Ophthalmology and Visual Sciences
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Jyoti Arora, Graduate Student/Weiner Lab

• Department: Cancer Center
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Natoshia M. Askelson, MPH, PhD

• Director for Community Outreach and Engagement
• Associate Professor

• Department: Community and Behavioral Health
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Interim Associate Director Community Outreach and Engagement

Vladimir Badovinac, PhD

• Professor

• Department: Pathology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Zuhair K. Ballas, MD

• Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Melissa L. Bates, PhD

• Associate Professor

• Department: Pediatrics, Health and Human Physiology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Reinhard R. Beichel, PhD, MS

• Professor

• Department: Electrical and Computer Engineering, Internal Medicine
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Andrew M. Bellizzi, MD

• Clinical Professor

• Department: Pathology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Daniel J. Berg, MD

• Associate Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Gail A. Bishop, PhD

• Associate Director of Basic Research for Holden Comprehensive Cancer Center
• Professor

• Department: Microbiology and Immunology, Internal Medicine
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Associate Director, Basic Research

Dustin Bosch, MD, PhD

• Assistant Professor of Pathology

• Department: Pathology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Terry Braun, PhD

• Professor

• Department: Ophthalmology and Visual Sciences, Biomedical Engineering
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Terry Braun , PhD

• Professor

• Department: Ophthalmology and Visual Sciences, Biomedical Engineering
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Qierra Brockman

• Graduate Research Assistant
• PhD Candidate

• Department: Internal Medicine
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

James A. Brown, MD

• Professor

• Department: Urology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

John M. Buatti, MD

• Department Chair
• Professor

• Department: Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Marisa R. Buchakjian, MD, PhD

• Emerging Leaders Council (ELC) Vice-Chair, Holden Comprehensive Cancer Center
• Assistant Professor

• Department: Otolaryngology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Garry R. Buettner, PhD

• Professor

• Department: Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

David L. Bushnell, Jr., MD

• Professor

• Department: Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Noah Butler, PhD

• Associate Professor

• Department: Microbiology and Immunology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

James Byrne, MD, PhD

• Assistant Professor

• Department: Radiation Oncology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

James D. Byrne, MD, PhD

• Assistant Professor

• Department: Radiation Oncology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Margaret Byrne, MD, MSc

• Clinical Assistant Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Colleen Campbell, PhD, MS, LGC

• Director of Genetic Counseling Operations

• Department: Internal Medicine
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Kevin P. Campbell, PhD

• Professor of Molecular Physiology and Biophysics
• Roy J. Carver Biomedical Research Chair

• Department: Molecular Physiology and Biophysics
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Guadalupe M. Canahuate, PhD

• Associate Professor

• Department: Electrical and Computer Engineering
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Lucas J. Carr, PhD

• Associate Professor

• Department: Health and Human Physiology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Calvin S. Carter, PhD

• Assistant Professor

• Department: Neuroscience and Pharmacology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Thomas Casavant, PhD

• Professor

• Department: Electrical and Computer Engineering, Biomedical Engineering, Ophthalmology and Visual Sciences
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Joseph M. Caster, MD, PhD

• Assistant Professor
• Director of Imaged Guided Brachytherapy

• Department: Radiation Oncology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

James Cerhan, MD, PhD

• Professor and Chair

• Department: Department of Epidemiology, Mayo Clinic, Rochester, Minn.
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Sena Chae, PhD, RN

• Assistant Professor

• Department: Nursing
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Carlos H.F. Chan, MD, PhD

• Associate Professor

• Department: Surgery
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Mary Charlton, PhD, BSN

• Associate Professor

• Department: Epidemiology, Director and Principal Investigator of the State Health Registry of Iowa/Iowa Cancer Registry
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Program Co-Leader

Anil K. Chauhan, MTech

• Professor

• Department: Internal Medicine
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Songhai Chen, MD, PhD

• Associate Professor

• Department: Neuroscience and Pharmacology, Internal Medicine
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Catherine H. Cherwin, PhD, MSN, RN

• Assistant Professor

• Department: Nursing
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Elizabeth Chrischilles, PhD

• Associate Director for Population Science
• Department of Epidemiology Chair
• Pomerantz Chair in Public Health
• Health Effectiveness Research Center Director
• Professor

• Department: Epidemiology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Associate Director, Population Science

Gary E. Christensen, DSc, MS

• Professor

• Department: Electrical and Computer Engineering, Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Gerald H. Clamon, MD

• Professor Emeritus

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Mitchell C. Coleman, PhD

• Assistant Professor

• Department: Radiation Oncology, Orthopedics and Rehabilitation
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

John D. Colgan, PhD

• Associate Professor

• Department: Internal Medicine
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Joseph Cullen, MD

• Professor
• VA Medical Center Chief of Surgical Services

• Department: Surgery
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Susan J. Curry, PhD

• Professor Emeritus, Health Management and Policy

• Department: Health Management and Policy
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Dao-Fu Dai, MD, PhD

• Assistant Professor

• Department: Pathology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Donghai Dai, MD, PhD

• Visiting Associate Professor

• Department: Obstetrics and Gynecology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Benjamin Darbro, MD, PhD

• Associate Professor

• Department: Pediatrics, Director, Shivanand R. Patil Cytogenetics and Molecular Laboratory
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Sanjana Dayal, PhD

• Associate Professor

• Department: Internal Medicine
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Kris A. DeMali, PhD

• Professor

• Department: Biochemistry
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Natalie Denburg, PhD, MA

• Associate Professor

• Department: Neurology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Anjali Deshpande, PhD, MPH

• Master of Public Health (MPH) Program Director
• Clinical Associate Professor

• Department: Epidemiology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Eric Devor, PhD

• Research Assistant Professor

• Department: Obstetrics and Gynecology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Prajwal Dhakal, MBBS

• Clinical Assistant Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

David W. Dick, PhD

• Clinical Associate Professor

• Department: Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

David Dickens, MD, FAAP

• Clinical Professor
• UI Dance Marathon Chair in Pediatric Oncology

• Department: Pediatrics
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Joseph S. Dillon, MD

• Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Rebecca D. Dodd, PhD

• Assistant Professor

• Department: Internal Medicine
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Program Co-Leader

Frederick E. Domann, PhD

• Professor Emeritus

• Department: Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Michael W. Duffel, PhD

• Professor
• College of Pharmacy Associate Dean for Research and Graduate Programs

• Department: Pharmaceutical Sciences and Experimental Therapeutics
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Adam J. Dupuy, PhD

• Associate Professor

• Department: Anatomy and Cell Biology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Po Hien Ear, PhD

• Research Assistant Professor

• Department: Surgery
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

John F. Engelhardt, PhD

• Professor
• Chair

• Department: Anatomy and Cell Biology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Umar Farooq, MD

• Clinical Associate Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Interim Outpatient Cancer Services Medical Director

Melissa A. Fath, PhD

• Associate Research Scientist

• Department: Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Naomi Fei, MD, MS

• Clinical Assistant Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Travis D. Fischer

• Graduate Research Assistant

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Rory A. Fisher, PhD

• Professor

• Department: Neuroscience and Pharmacology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Nicole Fleege, MD

• Clinical Assistant Professor

• Department: Internal Medicine
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Nicole MG Fleege, MD

• Clinical Assistant Professor

• Department: Internal Medicine
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Ryan T. Flynn, PhD

• Clinical Professor

• Department: Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Ernesto J. Fuentes, PhD

• Associate Professor

• Department: Biochemistry
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Laurence J. Fuortes, MD

• Professor Emeritus

• Department: Occupational and Environmental Health
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate
• Holden Leadership Role: Not Applicable

Muhammad Furqan, MD

• Medical Director of Clinical Research Services, Holden Comprehensive Cancer Center
• Clinical Associate Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Sukirth M. Ganesan, PhD, BDS

• Assistant Professor

• Department: Periodontics
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Sue E. Gardner, PhD, RN

• Professor

• Department: Nursing
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Jenna Gedminas, MD

• Clinical Assistant Professor

• Department: Pediatrics
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Fredric E. Gerr, MD

• Professor Emeritus

• Department: Occupational and Environmental Health
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Pamela K. Geyer, PhD

• Professor

• Department: Biochemistry
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Jesus Gonzalez Bosquet, MD, PhD

• Assistant Professor

• Department: Obstetrics and Gynecology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Michael J. Goodheart, MD

• Clinical Associate Professor

• Department: Obstetrics and Gynecology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

David J. Gordon, MD, PhD

• Associate Professor

• Department: Pediatrics
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Jessica S. Gorzelitz, PhD

• Assistant Professor

• Department: Health and Human Physiology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Prabhat Goswami, PhD

• Professor

• Department: Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Michael M. Graham, MD, PhD

• Professor

• Department: Radiation Oncology, Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Stephen A. Graves, PhD

• Assistant Professor

• Department: Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Irena Gribovskaja-Rupp, MD

• Clinical Associate Professor

• Department: Surgery
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Corinne E. Griguer, PhD

• Associate Professor

• Department: Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Isabella Grumbach, MD, PhD, FAHA

• Professor
• Vice Chair for Research

• Department: Internal Medicine, Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Wade R. Gutierrez

• Medical Scientist Training Program (MD/PhD) Trainee

• Department: Biology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Kristina Guyton, MD

• Clinical Assistant Professor

• Department: Surgery
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Hasem Habelhah, PhD

• Associate Professor

• Department: Pathology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Donna L. Hammond, PhD

• Professor
• Professor and Vice Chair of Research

• Department: Professor, Anesthesia, Neuroscience and Pharmacology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Emily M. Hammond

• Graduate Research Assistant

• Department: Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Marlan Hansen, MD

• Professor

• Department: Otolaryngology, Neurosurgery
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

John T. Harty, PhD

• Professor

• Department: Microbiology and Immunology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Imran Hassan, MBBS, FACS, FASCRS

• Clinical Professor

• Department: Surgery
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Bin Z. He, PhD

• Assistant Professor

• Department: Biology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Michael D. Henry, PhD

• Interim Director for Holden Comprehensive Cancer Center
• Professor

• Department: Molecular Physiology and Biophysics, Pathology, Radiation Oncology, Urology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Interim Director for Holden Comprehensive Cancer Center

Keela Herr, PhD, RN, FAAN, AGSF

• Professor
• College of Nursing Associate Dean for Faculty
• Co-Director of the Csomay Center for Gerontological Excellence

• Department: Adult and Gerontology Area of Study, John A. Hartford Center for Geriatric Nursing Excellence
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Richard D. Hichwa, PhD

• Senior Associate Vice President for Research
• Professor

• Department: Radiology, Radiation Oncology, Physics and Astronomy
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Emily Hill, MD

• Clinical Associate Professor

• Department: Obstetrics and Gynecology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Eric A. Hoffman, PhD

• Professor
• Advanced Pulmonary Physiomic Imaging Laboratory (APPIL) Director

• Department: Radiology, Nursing, Biomedical Engineering
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Henry T. Hoffman, MD

• Professor

• Department: Otolaryngology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Richard M. Hoffman, MD, MPH

• Professor

• Department: Internal Medicine, Epidemiology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Carol J. Holman, MD, PhD

• Clinical Professor

• Department: Pathology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

James H. Holmes, PhD

• Research Assistant Professor

• Department: Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Keri C. Hornbuckle, PhD

• Professor

• Department: Civil and Environmental Engineering
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Hisakazu Hoshi, MD

• Co-Leader Melanoma MOG
• Associate Deputy Director for Clinical Cancer Services for Holden Comprehensive Cancer Center
• Clinical Professor

• Department: Surgery
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Associate Deputy Director, Clinical Cancer Services

Bruce S. Hostager, PhD

• Associate Research Scientist

• Department: Microbiology and Immunology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Jon C. Houtman, PhD

• Associate Director of Career Enhancement at Holden Comprehensive Cancer Center
• Professor

• Department: Internal Medicine, Microbiology and Immunology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Associate Director, Career Enhancement

Michelle E. Howard, PhD

• Assistant Professor

• Department: Radiation Oncology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

James Howe, MD

• Co-Leader Gastrointestinal Neuroendocrine MOG
• Professor

• Department: Surgery
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Jennifer Hrabe, MD

• Clinical Associate Professor

• Department: Surgery
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Jian Huang, PhD

• Professor Emeritus

• Department: Statistics and Actuarial Science, Biostatistics
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Yi Huang, PhD

• Associate Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

M. Nedim N. Ince, MD

• Clinical Associate Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Kaikobad Irani, MD

• Professor

• Department: Internal Medicine
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Marina Ivanovic, MD

• Clinical Professor
• Holden Comprehensive Cancer Center Director of Thoracic Pathology

• Department: Pathology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Ali Jabbari, MD, PhD

• Associate Professor

• Department: Dermatology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Mathews Jacob, PhD

• Professor

• Department: Electrical and Computer Engineering
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Asad Javed, MBBS

• Clinical Assistant Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Zhendong Jin, PhD

• Professor

• Department: Medicinal and Natural Products
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Amanda R Kahl, MPH

• Research Specialist, State Health Registry of Iowa
• Adjunct Instructor

• Department: Epidemiology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Daniel Kahn, MD

• Professor Emeritus

• Department: Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Zizhen Kang, PhD

• Assistant Professor

• Department: Pathology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Simon C. S. Kao, MBBS, DMRD, FRCR, FACR

• Professor

• Department: Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Nitin J. Karandikar, MD, PhD

• Professor
• Chair

• Department: Pathology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Mark W. Karwal, MD

• Clinical Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Daniel Katz, MD

• Associate Professor

• Department: Surgery
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

David Katz, MD

• Associate Professor

• Department: Internal Medicine, Epidemiology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Robert J. Kerns, PhD

• Professor
• Pharmaceutical Sciences and Experimental Therapeutics Department Chair

• Department: Pharmaceutical Sciences and Experimental Therapeutics
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Jong Sung Kim, PhD

• Associate Professor

• Department: Occupational and Environmental Health
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Aloysius J. Klingelhutz, PhD

• Professor

• Department: Microbiology and Immunology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

C. Michael Knudson, MD, PhD

• Clinical Professor

• Department: Pathology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Amnon Kohen, DSc

• Professor Emeritus

• Department: Chemistry
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Geeta Lal, MD

• Professor
• Associate Chief Medical Officer (CMO)
• Adult Inpatient Director

• Department: Surgery
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Douglas E. Laux, MD, MS

• Co-Leader of the Head and Neck Cancer MOG
• Clinical Associate Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Gloria Lee, PhD

• Professor Emeritus

• Department: Internal Medicine
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Kevin L. Legge, PhD

• Professor

• Department: Pathology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Hans-Joachim Lehmler, PhD

• Professor

• Department: Occupational and Environmental Health
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Caitlin D. Lemke-Miltner, PhD

• Assistant Research Scientist

• Department: Cancer Center
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Steven R. Lentz, MD, PhD

• Professor

• Department: Internal Medicine
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Barcey T. Levy, MD, PhD

• Professor

• Department: Family Medicine
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Bing Li, PhD

• Professor

• Department: Pathology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Fang Lin, MD, PhD

• Associate Professor

• Department: Anatomy and Cell Biology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Joshua J. Lingo

• Graduate Research Assistant

• Department: Neuroscience and Pharmacology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Brian K. Link, MD

• Professor

• Department: Internal Medicine
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Vincent Liu, MD, FAAD

• Clinical Professor

• Department: Dermatology, Pathology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Ingrid Lizarraga, MBBS

• Clinical Associate Professor

• Department: Surgery
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Barry London, MD, PhD

• Professor

• Department: Internal Medicine
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

David M. Lubaroff, PhD

• Professor Emeritus

• Department: Urology, Microbiology and Immunology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Gabriele Ludewig, MS, PhD

• Professor

• Department: Occupational and Environmental Health
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Jia Luo, PhD

• Professor

• Department: Pathology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Yi Luo, MD, PhD

• Professor

• Department: Urology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Susan K. Lutgendorf, PhD

• Professor

• Department: Psychological and Brain Sciences, Obstetrics and Gynecology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Charles F. Lynch, MD, PhD

• Professor Emeritus

• Department: Epidemiology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Deqin Ma, MD, PhD

• Clinical Associate Professor

• Department: Pathology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Mark T. Madsen, PhD

• Professor Emeritus

• Department: Radiology, Physics and Astronomy
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Margarida Magalhaes-Silverman, MD

• Clinical Professor
• Director of the Blood and Marrow Transplant Program

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Vincent A. Magnotta, PhD

• Professor

• Department: Radiology, Psychiatry, Biomedical Engineering
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Kate Magsamen-Conrad, PhD

• Associate Professor

• Department: Communication Studies
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Adam W. Mailloux, PhD

• Assistant Professor
• Director of Cancer Cellular Therapy Research

• Department: Microbiology and Immunology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Anna Malkova, PhD

• Professor

• Department: Biology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

John Manak, PhD

• Professor

• Department: Biology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Ashutosh K. Mangalam, PhD

• Associate Professor

• Department: Pathology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Thorsten Maretzky, PhD

• Assistant Professor

• Department: Internal Medicine
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Molly E. Martin, PhD, PharmD

• Nuclear Pharmacist

• Department: Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Wendy J. Maury, PhD

• Professor

• Department: Microbiology and Immunology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Bradley D. McDowell, PhD

• Holden Comprehensive Cancer Center Population Research Core Director

• Department: Cancer Center
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Claudia R. Mello-Thom, PhD

• Research Associate Professor

• Department: Radiology, Biomedical Engineering
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Yusuf Menda, MD

• Professor

• Department: Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Program Co-Leader

Xiangbing Meng, PhD

• Research Associate Professor

• Department: Pathology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Mohammed M. Milhem, MBBS

• Holden Chair of Experimental Therapeutics
• Associate Director of Clinical Research and Melanoma Program Director-Holden Comprehensive Cancer Center
• Director-Division of Hematology, Oncology, and Blood & Marrow Transplantation
• Clinical Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Associate Director, Clinical Research

Benjamin J. Miller, MD, MS

• Co-Leader of the Sarcoma MOG
• Professor

• Department: Orthopedics and Rehabilitation
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Joseph M. Modrick, PhD

• Clinical Assistant Professor

• Department: Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Craig Morita, MD, PhD

• Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Scott Moye-Rowley, PhD

• Professor

• Department: Molecular Physiology and Biophysics
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Sarah Nash, PhD, MPH

• Adjunct Assistant Professor

• Department: Epidemiology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Marcus Nashelsky, MD

• Clinical Professor

• Department: Epidemiology and Pathology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Kenneth G. Nepple, MD

• Clinical Professor

• Department: Urology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Michael O'Donnell, MD

• Professor

• Department: Urology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

M. Sue O'Dorisio, MD, PhD

• Professor Emeritus

• Department: Pediatrics
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Michael A. O'Rorke, PhD

• Assistant Professor

• Department: Epidemiology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Jacob J. Oleson, PhD

• Professor

• Department: Biostatistics
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Claudia R. Oliva, PhD

• Research Assistant Professor

• Department: Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Vignesh Packiam, MD

• Clinical Assistant Professor

• Department: Urology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Nitin A. Pagedar, MD, MPH

• Co-Leader of the Head and Neck Cancer MOG
• Associate Professor

• Department: Otolaryngology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Edith A. Parker, MPH, DrPH

• Dean, College of Public Health
• Professor, Community & Behavioral Health

• Department: Community and Behavioral Health, Director, Prevention Research Center for Rural Health
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Stanley Perlman, MD, PhD

• Professor

• Department: Microbiology and Immunology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Sneha Phadke, DO, MPH

• Clinical Associate Professor

• Department: Internal Medicine
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Bryan T. Phillips, PhD

• Associate Professor

• Department: Biology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Robert C. Piper, PhD

• Professor

• Department: Molecular Physiology and Biophysics
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Laura Ponto, PhD

• Professor Emeritus

• Department: Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Jennifer G. Powers, MD

• Visiting Associate Professor

• Department: Dermatology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Sarv Priya, MD

• Clinical Assistant Professor
• Director of Cardiac Imaging
• Medical Director of 3D Lab

• Department: Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Miles A. Pufall, PhD

• Associate Professor

• Department: Biochemistry
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Dawn E. Quelle, PhD

• Professor

• Department: Neuroscience and Pharmacology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Program Co-Leader

Alexis R. Ramos

• Graduate Research Assistant

• Department: Microbiology and Immunology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Alan Reed, MD, MBA

• Professor

• Department: Surgery
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Kevin G. Rice, PhD

• Professor

• Department: Medicinal and Natural Products
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Larry W. Robertson, PhD, MPH

• Professor Emeritus

• Department: Occupational and Environmental Health
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Robert A. Robinson, MD, PhD

• Professor

• Department: Pathology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

William M. Rockey, MD, PhD

• Clinical Associate Professor

• Department: Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Richard J. Roller, PhD

• Professor

• Department: Microbiology and Immunology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

David L. Roman, PhD

• Professor

• Department: Medicinal and Natural Products
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Paul Romitti, PhD

• Professor

• Department: Biostatistics, Epidemiology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Thomas Rutkowski, PhD

• Associate Professor

• Department: Anatomy and Cell Biology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Shakoora Sabree

• Graduate Research Assistant

• Department: Medical Scientist Training Program (MSTP)
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Audrey Saftlas, MPH, PhD

• Professor Emeritus

• Department: Epidemiology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Aliasger K. Salem, PhD

• Associate Vice President for Research, University of Iowa
• Bighley Chair and Professor of Pharmaceutical Sciences

• Department: Pharmaceutics
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Program Co-Leader

Todd Scheetz, PhD

• Professor

• Department: Ophthalmology and Visual Sciences, Biomedical Engineering
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Aaron Scherer, PhD

• Assistant Professor

• Department: Internal Medicine
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Annette J. Schlueter, MD, PhD

• Clinical Professor

• Department: Pathology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Michael J. Schnieders, PhD

• Associate Professor

• Department: Biochemistry, Biomedical Engineering
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Mary C. Schroeder, PhD

• Associate Professor

• Department: Pharmacy Practice and Science
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Michael K. Schultz, PhD

• Associate Professor

• Department: Radiation Oncology, Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Aaron Seaman, PhD

• Emerging Leaders Council (ELC) Chair, Holden Comprehensive Cancer Center
• Assistant Professor

• Department: Internal Medicine
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Anjali A. Sharathkumar, MBBS, MD

• Clinical Professor

• Department: Pediatrics
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Saima Sharif, MD, MS

• Clinical Associate Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Alexa P. Sheehan

• Graduate Research Assistant
• PhD Student

• Department: Internal Medicine
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Val Sheffield, MD, PhD

• Professor

• Department: Pediatrics
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Joel Shilyansky, MD

• Professor
• Robert and Hélène Soper Chair of Pediatric Surgery
• Surgeon-in-Chief

• Department: Surgery, Pediatrics
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Jessica C. Sieren, PhD

• Associate Professor

• Department: Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Andrean L. Simons-Burnett, PhD

• Associate Director of Diversity, Equity and Inclusion (DEI)
• Holden Comprehensive Cancer Center Diversity Task Force Chair
• Associate Professor

• Department: Pathology, Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Holden Comprehensive Cancer Center Diversity Task Force Chair

Kelly W. Sittig

• Iowa Cancer Consortium Executive Director

• Department: Cancer Center
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Diane Slusarski, PhD

• Professor Emeritus

• Department: Biology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Brian J. Smith, PhD

• Professor

• Department: Biostatistics
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Mark C. Smith, MD

• Clinical Professor

• Department: Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Linda G. Snetselaar, PhD

• Professor

• Department: Epidemiology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

David R. Soll, PhD

• Professor Emeritus

• Department: Biology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Shane R. Solst, PhD

• Postdoctoral Research Scholar

• Department: Radiation Oncology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Milan Sonka, PhD

• Professor

• Department: Electrical and Computer Engineering, Ophthalmology and Visual Sciences, Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Maria Spies, PhD

• Professor

• Department: Biochemistry
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Douglas R. Spitz, Jr., PhD

• Professor

• Department: Radiation Oncology, Pathology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Program Co-Leader

Mark Stamnes, PhD

• Associate Professor

• Department: Internal Medicine, Molecular Physiology and Biophysics
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Jack T. Stapleton, MD

• Professor

• Department: Internal Medicine
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Christopher S. Stipp, PhD

• Associate Professor

• Department: Biology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Christopher Strouse, MD

• Clinical Assistant Professor

• Department: Internal Medicine
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Sonia Sugg, MD

• Clinical Professor
• Medical Director of the Breast Center
• Co-Leader of the Breast MOG

• Department: Surgery
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Wenqing Sun, MD, PhD

• Clinical Associate Professor

• Department: Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Yuanlu Sun, PhD, BSN

• Assistant Professor

• Department: Nursing
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

John Sunderland, PhD

• Professor

• Department: Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Grerk Sutamtewagul, MD

• Clinical Assistant Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Erin E. Talbert, PhD

• Assistant Professor

• Department: Health and Human Physiology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Munir R. Tanas, MD

• Associate Professor

• Department: Pathology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Eric B. Taylor, PhD

• Associate Professor

• Department: Biochemistry
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Kristina W. Thiel, PhD

• Assistant Professor

• Department: Obstetrics and Gynecology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Peter S. Thorne, PhD

• Professor and Director

• Department: Occupational and Environmental Health
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Michael H. Tomasson, MD

• Professor

• Department: Internal Medicine
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Fatima Toor, PhD

• Associate Professor

• Department: Electrical and Computer Engineering, Physics and Astronomy
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Tina Tootle, PhD

• Professor

• Department: Anatomy and Cell Biology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Chad Tracy, MD

• Clinical Professor
• Director of Minimally Invasive Surgery and Kidney Stone Treatment

• Department: Radiology, Urology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Jessica M. Tucker, PhD

• Assistant Professor

• Department: Microbiology and Immunology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Slyn Uaroon

• Research Assistant

• Department: Otolaryngology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Aliye Uc, MD

• Professor

• Department: Pediatrics
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Marta J. Van Beek, MD, MPH, FAAD

• Clinical Professor

• Department: Dermatology
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Mark W. Vander Weg, PhD

• Professor
• Head of Community and Behavioral Health

• Department: Community and Behavioral Health, Internal Medicine, Psychological and Brain Sciences
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Program Co-Leader

Mary S. Vaughan-Sarrazin, PhD

• Associate Professor

• Department: Internal Medicine
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Suresh Veeramani, DVM, PhD

• Research Assistant Professor

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Ellen Voigt

• Graduate Student

• Department: Neuroscience and Pharmacology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Thaddeus J. Wadas, PhD

• Associate Professor

• Department: Radiology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Thomas J. Waldschmidt, PhD

• Professor

• Department: Pathology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Robert B. Wallace, MD

• Professor Emeritus

• Department: Epidemiology, Internal Medicine
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Lori Wallrath, PhD

• Professor

• Department: Biochemistry
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Kai Wang, PhD

• Professor

• Department: Biostatistics
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

M. Todd Washington, PhD

• Professor

• Department: Biochemistry
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Shannon Lea Watkins, PhD

• Assistant Professor

• Department: Community and Behavioral Health
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Michelle Weckmann, MD, MS

• Clinical Associate Professor

• Department: Family Medicine
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Ronald Weigel, MD, PhD, MBA

• Professor
• Department Chair

• Department: Surgery
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

George J. Weiner, MD

• Director Emeritus for Holden Comprehensive Cancer Center
• Professor

• Department: Pharmaceutical Sciences and Experimental Therapeutics, Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Director Emeritus for Holden Comprehensive Cancer Center

Michele M. West, PhD

• Associate Research Scientist

• Department: State Health Registry
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Amy L. Whillock

• Graduate Student

• Department: Microbiology and Immunology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Stephanie H. White, PhD, APRN-C

• Nurse Practitioner

• Department: Nursing
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

David F. Wiemer, PhD

• Professor

• Department: Chemistry
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Marc S. Wold, PhD

• Professor

• Department: Biochemistry
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Michael Wright, PhD

• Associate Professor

• Department: Molecular Physiology and Biophysics
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Li Wu, PhD

• Professor

• Department: Microbiology and Immunology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Xiaodong Wu, PhD

• Professor

• Department: Electrical and Computer Engineering, Radiation Oncology
• Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Xian Jin Xie, PhD

• College of Dentistry Associate Dean for Research
• Division of Biostatistics and Computational Biology Centennial Professor and Director
• Professor

• Department: Preventive and Community Dentistry
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Shujie Yang, PhD

• Assistant Professor

• Department: Pathology
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Charles Yeaman, PhD

• Associate Professor

• Department: Anatomy and Cell Biology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Nanmeng Yu, MD, PhD

• Associate

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Whitney E. Zahnd, PhD

• Assistant Professor

• Department: Health Management and Policy
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Yousef Zakharia, MD

• Clinical Associate Professor
• Director Phase I Program
• Co-Leader Genitourinary Oncology Program

• Department: Internal Medicine
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable

Gideon K. D. Zamba, PhD

• Professor

• Department: Biostatistics
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Erliang Zeng, PhD

• Associate Professor

• Department: Preventive and Community Dentistry, Biostatistics
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Full Member
• Holden Leadership Role: Not Applicable

Kang Zhao, PhD

• Associate Professor

• Department: Management Sciences
• Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Eliot Y. Zhu, MS

• Graduate Research Assistant

• Department: Anatomy and Cell Biology
• Program: Program 1: Cancer Genes and Pathways (CGP)
• Membership Status: Affiliate Member
• Holden Leadership Role: Not Applicable

Jessica A.O. Zimmerman, MD, MS

• Assistant Professor

• Department: Pediatrics
• Program: Program 2: Experimental Therapeutics (ET)
• Membership Status: Associate Member
• Holden Leadership Role: Not Applicable